There are no clinically relevant treatments available that improve function in the growing population of very preterm infants (less than 32 weeks' gestation) with neonatal brain injury. Diffuse white matter injury (DWMI) is a common finding in these children and results in chronic neurodevelopmental impairments 1,2 . As shown recently, failure in oligodendrocyte progenitor cell maturation contributes to DWMI 3 . We demonstrated previously that the epidermal growth factor receptor (EGFR) has an important role in oligodendrocyte development 4 . Here we examine whether enhanced EGFR signalling stimulates the endogenous response of EGFR-expressing progenitor cells during a critical period after brain injury, and promotes cellular and behavioural recovery in the developing brain.
There are no clinically relevant treatments available that improve function in the growing population of very preterm infants (less than 32 weeks' gestation) with neonatal brain injury. Diffuse white matter injury (DWMI) is a common finding in these children and results in chronic neurodevelopmental impairments 1, 2 . As shown recently, failure in oligodendrocyte progenitor cell maturation contributes to DWMI 3 . We demonstrated previously that the epidermal growth factor receptor (EGFR) has an important role in oligodendrocyte development 4 . Here we examine whether enhanced EGFR signalling stimulates the endogenous response of EGFR-expressing progenitor cells during a critical period after brain injury, and promotes cellular and behavioural recovery in the developing brain.
Using an established mouse model of very preterm brain injury, we demonstrate that selective overexpression of human EGFR in oligodendrocyte lineage cells or the administration of intranasal heparinbinding EGF immediately after injury decreases oligodendroglia death, enhances generation of new oligodendrocytes from progenitor cells and promotes functional recovery. Furthermore, these interventions diminish ultrastructural abnormalities and alleviate behavioural deficits on white-matter-specific paradigms. Inhibition of EGFR signalling with a molecularly targeted agent used for cancer therapy demonstrates that EGFR activation is an important contributor to oligodendrocyte regeneration and functional recovery after DWMI. Thus, our study provides direct evidence that targeting EGFR in oligodendrocyte progenitor cells at a specific time after injury is clinically feasible and potentially applicable to the treatment of premature children with white matter injury.
Chronic neonatal hypoxia is a clinically relevant model of premature brain injury caused by insufficient gas exchange from poor lung development 5 . This 'hypoxic' state is a major contributor to DWMI-a common finding in infants born very preterm (VPT)-resulting in sensorimotor deficits that persist throughout their lifetime 1, 2, 6 . We used a mouse model of chronic hypoxia, which replicates DWMI and other neuropathological hallmarks of brain injury resulting from premature birth [7] [8] [9] .
The cellular and molecular mechanisms underlying DWMI in VPT children-and in chronic hypoxia-are unknown. It has been previously demonstrated that enhanced EGFR signalling in white matter oligodendrocyte lineage cells promotes their proliferation, migration, myelination and remyelination in the adult 4, 10 . We observed a significant increase in endogenous EGF levels in the white matter after chronic hypoxia (Extended Data Fig. 1 ). Therefore, we compared oligodendrocyte development in white matter injury and recovery in 29,39-cyclic nucleotide 39-phosphodiesterase (CNP) enhanced green fluorescent protein (eGFP) mice (Rep mice) and Rep mice in which human (h)EGFR was overexpressed in the oligodendrocyte lineage under the CNP promoter (Rep-hEGFR mice) 4, [11] [12] [13] . Hypoxia decreased myelin basic protein (MBP) expression in the white matter of Rep mice, but not in Rep-hEGFR mice ( Fig. 1a-e ). At postnatal day (P)60, MBP expression recovered in the hypoxia-treated Rep group (Fig. 1e ). At P11, chronic hypoxia did not cause any change in the number of Rep 1 Olig2 1 cells and mature (Rep 1 CC1 1 ) oligodendrocytes ( Fig. 1f ). At P18, we observed a decrease in Rep 1 Olig2 1 and Rep 1 CC1 1 oligodendrocytes in the white matter of hypoxia-treated Rep mice (Fig. 1g ), but no change in the Rep-hEGFR mice. Oligodendrocyte recovery was evident by P60 in the hypoxia-treated Rep group (Fig. 1h ).
There was an increase in apoptosis of oligodendrocyte lineage cells in Rep mice after hypoxia treatment at P11 and P18, but no change at P60 (Extended Data Fig. 2e ). No significant apoptosis was observed in Rep-hEGFR mice (Extended Data Fig. 2e ). Hypoxia caused an increase in the number of propidium iodide (PI) 1 cells (data not shown) and Rep 1 PI 1 cells (Extended Data Fig. 2a-d, f ). This increase was not observed in Rep-hEGFR mice. These results indicate that enhanced EGFR expression prevents oligodendrocyte loss by decreasing cell death after exposure to chronic hypoxia.
We next assessed the effects of hypoxia on oligodendrocyte progenitor (Rep 1 NG2 1 ) cells (OPCs) in the white matter (Extended Data Fig. 2g-k) . Enhanced hEGFR expression caused an increase in Rep 1 NG2 1 OPCs at P11 and P18 (normoxia Rep mice versus normoxia Rep-hEGFR mice; Extended Data Fig. 2k ). Hypoxia caused a significant increase in white mater OPCs in both Rep and Rep-hEGFR mice at the same ages (Extended Data Fig. 2k ). Similar findings were obtained after assessing proliferation of Rep 1 oligodendrocyte lineage cells (Extended Data Fig. 2l ). Enhanced hEGFR expression increased Rep 1 NG2 1 OPC proliferation in the normoxia group, and had an additive effect on hypoxia-induced OPC proliferation (Extended Data Fig. 2m ). Enhanced hEGFR expression increased oligodendrogenesis at P18, but, at P30, no difference was evident between hypoxia-treated Rep and hypoxia-treated Rep-hEGFR mice (Fig. 1i ). These results indicate that enhanced hEGFR expression in oligodendrocytes promoted the generation of new oligodendrocytes after chronic hypoxia.
We used electron microscopy to determine whether chronic hypoxia caused myelination abnormalities, and to assess whether EGFR overexpression rescued these abnormalities. (Fig. 1j-o) . At P60, when oligodendrocyte cell numbers and MBP expression recovered, myelination was still abnormal after hypoxia ( Fig. 1j-o ). Hypoxia caused a significant increase in the g ratio and hEGFR expression prevented this increase ( Fig. 1n, o) .
Next, we investigated behavioural deficits resulting from DWMI after perinatal chronic hypoxia by using subcortical white-matter-dependent sensorimotor behavioural tests (complex wheel and inclined beamwalking task) [14] [15] [16] [17] [18] . In the complex wheel task, there was no difference in training maximum velocity (V max ) between all four groups ( Fig. 1p ). On day 15, all four groups had a decline in V max ; however, the largest decline was in the hypoxia-treated Rep group (Fig. 1p ). The hypoxiatreated Rep group performed poorly on the complex wheel (days [15] [16] [17] [18] [19] [20] [21] , as compared to the other three groups ( Fig. 1p ), suggesting altered subcortical white matter integrity.
The inclined beam-walking task 17, 18 requires subcortical white matter integrity (Extended Data Fig. 3a -c) and no difference was observed between Rep mice and C57BL/6 mice (Extended Data Fig. 3d ). At P30, the hypoxia-treated Rep group displayed more foot slips than the normoxia Rep group (Fig. 1q ). Hypoxia-treated Rep-hEGFR mice showed no significant increase in the number of foot slips as compared with the normoxia Rep-hEGFR group. At P60, the hypoxia-treated Rep group continued to show an increase in number of foot slips, and no difference was seen in the hypoxia-treated Rep-hEGFR group (Fig. 1r ). These behavioural studies confirm that exposure to chronic hypoxia during a critical period in myelin development results in poor performance on white-matter-specific behavioural tasks. Enhanced EGFR activity prevents the effects of hypoxia, strongly suggesting that EGFR signalling in oligodendrocyte lineage cells has a crucial role in white matter recovery after perinatal injury.
We directly tested the role of endogenous EGFR signalling in oligodendrocyte recovery after hypoxia by gefitinib administration from P12-P18 ( Fig. 2a ). Gefitinib, a specific EGFR antagonist 19 , caused a small reduction in basal phosphorylated (p)EGFR levels in the white matter of normoxia mice at P18, but completely prevented the increase in pEGFR induced by hypoxia ( Fig. 2b ). Gefitinib caused a decrease of white matter Rep 1 Olig2 1 and Rep 1 CC1 1 oligodendrocyte lineage cells in normoxia mice ( Fig. 2c ). Hypoxia resulted in a decrease of these cell populations, which were further reduced by gefitinib ( Fig. 2c ). This decrease was attributed to a significant increase in oligodendrocyte apoptosis in both normoxia and hypoxia groups (Fig. 2d ). Gefitinib also decreased NG2 1 OPCs in the white matter of normoxia mice, and prevented the increase observed after hypoxia ( Fig. 2e ). Similarly, gefitinib decreased white matter oligodendrocyte linage cell proliferation in normoxia mice and prevented the proliferative response observed after hypoxia ( Fig. 2f ). Gefitinib also decreased Sox2-and Ascl1-expressing progenitors (Extended Data Fig. 4a-j) . At P30, gefitinib still caused a decrease in oligodendrocyte lineage cells and mature oligodendrocytes in normoxia mice, and prevented oligodendrocyte recovery and oligodendrogenesis observed after hypoxia ( Fig. 2g, h ). Finally, gefitinib prevented the recovery in CNPase and MBP protein levels observed after hypoxia at P30 (Fig. 2i ). These results confirm that endogenous EGFR signalling is important in white matter cellular and biochemical recovery after hypoxia. q, Naive mice were tested on the 2-cm-and 1-cm-width inclined beam-walking task (Poisson multiple regression analysis; Nx Rep, n 5 8; Nx Rep-hEGFR, n 5 10; Hyp Rep, n 5 10; Hyp Rep-hEGFR, n 5 10). r, A separate group of naive mice was assessed (Poisson multiple regression analysis; Nx Rep, n 5 9; Nx Rep-hEGFR, n 5 8; Hyp Rep, n 5 10; Hyp Rep-hEGFR, n 5 9). Line graph and histograms are presented as means 6 standard error of the mean (s.e.m.). *P 5 0.05; **P , 0.05; ***P , 0.01.
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We wanted to examine whether directly targeting EGFR with a selective ligand (recombinant heparin-binding EGF (HB-EGF)) delivered through the intranasal route promoted cellular recovery of white matter oligodendrocytes after hypoxia. The clinical relevance of targeting endogenous oligodendrocytes was demonstrated by the presence of EGFRexpressing oligodendrocyte lineage cells (Olig2 1 EGFR 1 ) in neonatal preterm human white matter (Fig. 3a ). The intranasal route allows rapid drug delivery directly to the brain from the nasal mucosa [20] [21] [22] . HB-EGF via the intranasal route enters the brain 20, 23 and acts on the white matter (Extended Data Fig. 5a -c), where Rep 1 pEGFR 1 cells could be identified (Extended Data Fig. 5d ). FACS purification of hypoxia-exposed white matter Rep 1 cells after HB-EGF treatment directly demonstrated activation of EGFR in oligodendrocyte lineage cells (Extended Data Fig. 5e ). Treatment with seven doses of intranasal HB-EGF from P11-P14 ( Fig. 3b 
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prevented white matter oligodendrocyte lineage cell loss after hypoxia ( Fig. 3c ). Rep 1 cells were stained for caspase 3 in all groups. At all ages examined, HB-EGF treatment reduced (P15) or prevented (P18) the effects of hypoxia on oligodendrocyte cell death ( Fig. 3d ). HB-EGF treatment also caused an increase in white matter Rep 1 NG2 1 OPCs in both normoxia and hypoxia groups, and enhanced OPC proliferation 24 (Fig. 3e , f). To determine whether oligodendrocyte recovery was a result of increased oligodendrogenesis from this expanded pool of proliferative OPCs, we performed BrdU-pulse chase labelling of newly generated oligodendrocytes. HB-EGF increased the number of Rep 1 CC1 1 BrdU 1 cells under normoxic and hypoxic conditions at P18 ( Fig. 3g ). At P30, the additive effect of hypoxia and HB-EGF was not as evident ( Fig. 3g ). Genetic lineage tracing of oligodendrocytes in vivo by using the platelet-derived growth factor-a receptor (PDGFaR-CreER: Z/EG) (GFP 1 ) reporter mouse 25 (Extended Data Fig. 6 and Fig. 3h ) confirmed that hypoxia and HB-EGF treatment have an additive effect on the generation of Olig2-expressing cells (Extended data Fig. 6j ). Conversely, PDGFaR-driven EGFR deletion in OPCs prevented the cellular effects of HB-EGF on NG2 1 OPCs (Fig. 3i ). HB-EGF treatment after hypoxia also resulted in recovery of MBP and proteolipid protein (PLP) expression ( Fig. 3j ). These results indicate that, after hypoxia, HB-EGF promotes expansion of the OPC pool, and oligodendrocyte regeneration and maturation.
Electron microscopy analysis revealed that HB-EGF treatment rescued the increase in g ratio observed in hypoxia-treated mice and partially prevented the decrease in percentage of myelinated axons (Fig. 4a-f and Extended Data Fig. 7 ). Diffusion tensor imaging (DTI) demonstrated that, at P60, fractional anisotropy (FA) values are significantly decreased in the corpus callosum, cingulum and external capsule regions of hypoxiatreated mice, but not in the HB-EGF-treated hypoxia group (Fig. 4g-j) . Electrophysiological analysis of extracellular compound action potentials (CAPs) demonstrated that HB-EGF prevented the decrease in 
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amplitude of myelinated axons observed after hypoxia (Fig. 4k ). Finally, analysis of N-acetylaspartate (NAA) in the white matter showed decreased levels at P18 and P30, which was prevented by HB-EGF ( Fig. 4l and Extended Data Fig. 8 ).
On the complex wheel, hypoxia-exposed HB-EGF-treated mice showed a similar performance to the normoxia saline-treated group (Fig. 4m ). Furthermore, in the inclined beam-walking task, HB-EGF treatment completely prevented hypoxia-induced behavioural deficit, as tested on the 2-cm-width beam, and reduced the effects of hypoxia on performance on the 1-cm-width beam (Fig. 4n, o) . Importantly, when HB-EGF treatment was performed at P18-P21, it had no effect on the hypoxiainduced behavioural phenotype (Fig. 4p and Extended Data Fig. 9 ).
Importantly, HB-EGF strongly inhibited hypoxia-induced upregulation of Notch signalling elements (Extended Data Fig. 10a-c) and functional activation of Notch in white matter Olig2 1 oligodendrocyte lineage cells (Extended Data Fig. 10d-h) , which could be at least in part responsible for delayed oligodendrocyte maturation after perinatal injury 26 . These results are consistent with the notion that HB-EGF accelerated OPC maturation after hypoxia through inhibition of Notch 11 , and indicates that HB-EGF treatment promotes functional recovery during a critical developmental time window for effective therapeutic intervention.
Our results reveal that activating EGF/EGFR signalling promotes cellular and functional recovery after neonatal brain injury. Enhancing EGFR signalling through overexpression of the EGFR prevents DWMI, promotes the generation of new oligodendrocytes and prevents behavioural deficits in different white-matter-related tasks. Furthermore, a brief pharmacological treatment that targets endogenous EGFRs using a clinically feasible (intranasal) mode of entry during a critical window promotes cellular, developmental and myelin structural improvement, and behavioural recovery. Intranasal treatment is a plausible route to introduce sufficient HB-EGF into the brain and white matter of critically ill VPT infants.
METHODS SUMMARY
Data presented are from male mice on a C57BL/6 background. Mice underwent chronic perinatal hypoxia from P3-P11, as previously described 27, 28 . In the first set of experiments, Rep mice that did not express hEGFR were used as littermate controls. The EGFR antagonist gefitinib (AstraZeneca) was administered intraperitoneally at 75 mg kg 21 body weight once daily for 7 days. Normoxia and hypoxia control groups received vehicle on the same days and times. HB-EGF was administered intranasally at a concentration of 100 ng g 21 body weight in 5 ml increments separated by 10 min. Equal volumes of saline were used as a vehicle control.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Animals. The CNP-EGFP (Rep) and CNP-EGFP-hEGFR (Rep-hEGFR) strains were generated as described previously and backcrossed to a C57BL/6 genetic background greater than nine generations 4, 11, 12 . The Rep-hEGFR mice used for these experiments were crossed with heterozygote Rep mice to ensure that all pups were positive for GFP, but not all expressed hEGFR. This ensured littermate controls. For experiments that required only the Rep line of mice, a Rep adult mouse was crossed with a C57BL/6 adult mouse (Jackson Laboratories). Only mice that expressed eGFP (Rep) during screening on P2 with ultraviolet goggles were used. The PDGFaR-CreERT2 line (courtesy of D. Bergles; referred to in the text as PDGFaR-CreER) was crossed with Z/EG reporter mice (Jackson Laboratories; stock number 003920) and genotyped as previously reported 25 . Z/EG reporter mice were crossed with EGFR fl/fl (ref. 29 ) followed by PDGFaR-CreER transgenic mice. These mice were backcrossed to ensure homozygote EGFR fl/fl mice, so that all mice were PDGFaR-CreER;EGFR fl/fl ;Z/EG. To induce Cre recombination, tamoxifen was administered at a dosage of 75 mg g 21 body weight. The Ascl1 GFP mice (Jackson Laboratories, stock 012881; also known as Mash1) were used to determine the effects of gefitinib on white matter Ascl1-expressing cells. Unless described later or in the figure legends, only male mice were used, owing to male preterm children showing more clinically relevant injury and neurological deficits compared with females 30, 31 . All animal procedures were performed according to the Institutional Animal Care and Use Committee of the Children's National Medical Center and the Guide for the Care and Use of Laboratory Animals (National Institutes of Health). Hypoxic rearing. Mice were randomly chosen to either undergo hypoxic rearing or serve as normoxia controls. The hypoxic mice were placed in a sealed chamber maintaining O 2 concentration at 10.5% by displacement with N 2 as described previously 27, 28, 32 . Hypoxia began at P3 for 8 days until P11. This time window in rodent white matter oligodendrocyte development reproduces changes that occur at 23-40 weeks of gestation in the human brain 9 . A separate group of mice from the same breeding cage were used for age-and strain-matched normoxia controls. Genotyping (CNP-hEGFR; PDGFaR-CreER;Z/EG; Ascl1 GFP ; EGFR fl/fl ; and Notch reporter mice) was performed at P11 by PCR of tissue obtained from the tail as previously reported 4, 11, 25, 29, 33 . Time points chosen for immunohistochemistry or protein quantification were P11, P14.5, P15, P18, P30 and P60. BrdU administration. The BrdU labelling protocol was performed in all mice as follows. Mice were injected intraperitoneally (i.p.) at the same time of the day with BrdU (50 mg g 21 body weight) daily for 4 days (P11-P14) in the morning. In studies using HB-EGF or gefitinib, BrdU was administered 1 h before vehicle or drug administration. Gefitinib administration. Gefitinib (Iressa; Astra Zeneca (Tocris)) was prepared with strong sonication in 25% dimethylsulphoxide (DMSO) and 75% sunflower seed oil at a concentration of 10 mg ml 21 . Male mice in each litter were randomly chosen to receive either drug or vehicle. The drug dose for this study was 75 mg kg 21 day 21 and was administered once daily. An equal amount of vehicle was administered to control animals. A total of seven doses of vehicle or drug were administered beginning at P12. HB-EGF administration. The intranasal route allows for small molecules to rapidly enter the cerebrospinal fluid from the nasal cavity, followed by subsequent distribution to the brain and spinal cord [34] [35] [36] [37] . Recombinant human heparin-binding epidermal growth factor constituent free (HB-EGF; R&D Biosciences) was prepared using 0.45% normal sterile saline solution at a concentration of 20 mg ml 21 and stored at 220 uC. Mice were randomized to the vehicle (saline) or HB-EGF group. Saline or HB-EGF was administered intranasally at no more than 5 ml increments 5-10 min apart for a total of 100 ng g 21 . The mouse was held ventralside up, and a small-modified 27-French catheter was inserted into either nare. Saline or drug was slowly administered and the mouse was held for 1-2 min to ensure absorption. Drug or saline was administered every 12 h beginning on the evening of P11. Immunohistochemistry and antibodies. Freshly cut, free-floating brain sections (40 mm thick) from P11-P60 mice were prepared as described previously 3, 11, 27, 32 . Primary antibody dilutions were 1:500 for anti-BrdU (Accurate), anti-NG2 (Millipore), anti-Olig2 (Millipore), anti-Ki67 (Vector), anti-APC (also referred as CC1; Millipore) and anti-cleaved caspase 3 (caspase 3; Millipore); 1:250 for anti-MBP (Covance); and 1:500 anti-EGFR phosphorylated Tyr 1068 (Novus Biologicals). Sections were incubated at room temperature (22-25 uC) for 1-3 h, followed by overnight at 4 uC in primary antibodies diluted in 0.1 M PBS containing 0.1% Triton X-100 and 5% normal goat serum (vol/vol). Three washes were performed with cold 1 PBS before secondary antibodies being administered. The secondary antibodies (1:200) used were AlexaFluor 488, AlexaFluor 546 and AlexaFluor 633 conjugated goat antirabbit, anti-rat or anti-mouse IgG (Invitrogen). Sections were incubated with secondary antibodies for 1 h at room temperature, followed by three 13 PBS washes. Sections were treated with 49,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) for 10-15 min at room temperature and mounted with Mowiol. Human tissue was obtained from a deceased 3-day-old infant born at 36-week gestation with approval from the Children's National Institutional Review Board. Sections of corpus callosum and periventricular region were removed after fixation of the brain for 2 weeks in formalin solution. Tissue was kept in PBS for 1 week with daily changes of PBS solution to remove excess formalin. The brain was then placed in 20% glycerol solution for 24 h. Freshly cut, free-floating sections (40 mm thick) were made on a sliding microtome. Sections were immunostained as described earlier. Microscopy and cell counting. All fluorescent images were taken on a Zeiss LSM confocal laser-scanning microscope with sequential scanning mode using 340 oil objectives. Microscopy and cell counting were performed as recently described 38, 39 . Z-stack images of 1-mm-thick single planes were captured throughout the entire thickness of the slice and each cell was analysed using a Zeiss LSM Image Browser (version 4.2) in its entire z-axis to exclude false double labelling due to overlay of signals from different cells. Four different laser lines were used to perform image localization of fluorescein isothiocyanate (FITC) (488 nm excitation; 522/35 emission filter), CY3 (560 nm excitation; 605/32 emission filter), Cy5 (647 nm excitation; 680/32 emission filter) and DAPI (400 nm excitation). Data acquisition and processing were controlled by modified LSM software. Analysis of immunofluorescence was performed on a confocal z-stack as previously described 38, 39 . Cells were counted in 225 3 225 3 10 mm (X, Y, Z planes) images for cells per volume quantifications. Data were obtained from an average of six tissue sections per mouse per immunostain. Analysis of subcortical white matter-rostral to the hippocampuswas performed in the corpus callosum, cingulum and external capsule. Cells were counted in a blinded fashion. The merged image for each confocal z-stack was analysed and positive immunofluorescence identified for each individual channel. Merged images were processed in Photoshop CS5.5 with minimal manipulation of contrast. Propidium iodide. To assess loss of membrane integrity and increased plasmalemma permeability in vivo, propidium iodide was used as demonstrated previously 40 . Propidium iodide (10 mg ml 21 ; Sigma) was diluted in 0.9% NaCl and 1 mg kg 21 was administered i.p. 1 h before mice were killed. As described earlier, mice were perfused, brains were collected from all groups and free-floating brain sections (40 mm thick) were prepared. Sections were washed, incubated with DAPI for 10 min, washed and then mounted on a slide. Propidium iodide (PI) emits bright red fluorescence when bound to RNA or DNA. Confocal microscopy was used to visualize the GFP 1 PI 1 DAPI 1 cells. Western blot analysis. For western blot analysis of white matter lysates, the subcortical white matter was dissected on ice-cold medium from 300-400-mm-thick sections as previously described 4, 27, 32 . Briefly, brains were sliced coronally and only sections anterior to the hippocampus were used. Using Roboz-a fine-straight and fine-angled microdissecting forceps under a dissecting microscope-the cortex was dissected away leaving the subcortical white matter attached to the striatum. The white matter was then easily pushed away from the striatum, leaving only white matter tissue. The dissected white matter was rinsed with ice-cold PBS, and then lysed on ice in 150-200 ml of RIPA lysis buffer with protease inhibitors. Protein concentrations were determined by using the Bradford protein assay kit (Bio-Rad). Western blot analysis was performed using 10-40 mg of total cell lysates. Proteins were resolved on 4-20% Tris glycine gels (NuSep) and transferred to Immobilon PVDF membranes in transfer buffer overnight at 4 uC. Membranes were blocked for 1 h in 5% milk in Tris-buffered saline-Tween 20 (TBST), then incubated at 4 uC overnight with primary antibodies diluted in 5% milk in TBST: 1:5,000 for anti-MBP (Covance), anti-CNP (Covance) and anti-actin (Millipore); 1:1,000 for anti-PLP (Abcam); 1:1,000 for anti-HB-EGF (Santa Cruz); 1:1,000 for anti-Delta1 (Santa Cruz); 1:1,000 for anti-NICD (Iowa Hybridoma Bank C17.9C6); and 1:4,000 for anti-aspartoacylase (ThermoScientific)). The membranes were then washed in TBST three times for 10-15 min at room temperature followed by the addition of either horseradish-peroxidase-conjugated goat polyclonal anti-rabbit IgG (Santa Cruz) for polyclonal primary antibodies, or horseradish-peroxidaseconjugated goat anti-mouse (Santa Cruz) for mouse monoclonal primary antibodies diluted in 5% milk in TBST. For phosphorylated EGFR (Novus Biologicals), 5% bovine serum albumin (BSA) in TBST was used as a block and for primary antibody incubation overnight. For all western blots, chemiluminescent signals were detected using Pierce ECL western blotting substrate. X-ray films were scanned using an Agfa T1200 scanner and densitometric measurements were obtained using ImageJ software (http://rsb.info.nih.gov/ij/). Western blots were obtained from the white matter of 3-6 male mice in each group. Densitometric measurements were obtained using ImageJ software averaged as previously described 4, 27, 32 . EGF ELISA. White matter was grossly dissected on ice-cold 13 PBS from P11, P15 and P18 Rep and Rep-hEGFR normoxia and hypoxia mice as described earlier. Assay procedure was performed according to the manufacturer's instructions (R&D Systems, Mouse EGF Quantikine ELISA Kit). Experiments were performed in triplicates and averaged.
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FACS. White matter microdissected tissue from hypoxia-exposed P15 Rep 1 (CNP-EGFP 1 ) vehicle-or HB-EGF-treated mice were FACS purified. Two-tothree male and female brains were pooled for each sample (individual n). Tissue was dissociated into single-cell suspensions as previously described 11, 41 , and analysed for light forward and side scatter using a FACSAria instrument (BD Bioscience). The collected Rep 1 cells were used for western blot analysis. Electron microscopy. Mice at P30 and P60 were perfused with 4% paraformaldehyde containing 10% picric acid and 5% glutaraldehyde and post-fixed for 2 weeks 42 . Brains were sectioned and prepared in groups at the same time as previously described 32, 42 . Sagittal sections of white matter were examined with a JEOL transmission electron microscope (JEM-1400), and pictures were taken with a Gatan SC1000 ORIUS CCD camera. Measurements and image processing was performed using ImageJ. Myelin thickness was calculated from the average of radial measurements at four points per sheath, avoiding areas of tongue processes or fixation artefact 42, 43 . Axon diameters were calculated from measurement of the axon circumference. Axons with diameters typical of unmyelinated fibres (,0.3 mm) were excluded from analysis 42, 43 . The extent of myelination was quantitatively compared by determining g ratios, which were calculated by dividing the diameter of the axon by the diameter of the entire myelinated fibre, as previously described [42] [43] [44] . Measurements were performed by J.S., who was blinded to groups. At least 100 axons were measured for each brain. LPC-induced demyelination. Bilateral demyelination was performed in adult male and female C57BL/6 (8 weeks old) mice after deep ketamine/xylazine anaesthesia (10 mg g 21 body weight). Mice were placed in a modified stereotaxic frame (Stoetling) and 2 ml of 2% lysolecithin (EMD Chemicals, LPC) solution (vol/vol) and/or 0.9% NaCl (vol/vol) was injected bilaterally into the corpus callosum using a Hamilton micropette (Stoetling). Injection time lasted for 5 min to reduce reflux along the needle track. The needle was then slowly withdrawn over a 5 min period. Stereotaxic coordinates for the corpus callosum were taken from Bregma (0.26 mm caudal, 1.0 mm lateral and 3.0 mm ventral). Inclined-beam walking behavioural test testing began 5 days after surgery in both groups of mice as described later. Bilateral demyelination was confirmed after testing by perfusing the mice as described earlier and immunohistochemical analysis of the corpus callosum was performed using anti-MBP. Only mice that displayed clear bilateral lesions on microscopic examination were included in the behavioural analysis. Three (n 5 3) mice were excluded from the study because bilateral white matter demyelination was not clearly evident. DTI analysis. Mice (P60) used for DTI were perfused and imaged as previously described 45 . One hour before DTI scans the brains were soaked 3 times for 10 min each time in 10 ml PBS to remove the PFA solution. The brains were placed into a custom-built MRI-compatible tube filled with Fluorinert-an MRI susceptibilitymatching fluid (Sigma-Aldrich). The DTI data sets were obtained on a 9.4 T horizontal bore magnet (Bruker) with a custom-made 1 H radio frequency coil. The DTI experiments were performed using the Stejskal-Tanner spin-echo diffusionweighted sequence with a diffusion gradient of 5 ms and a delay between the two diffusion gradients of 15 ms. Twenty-four contiguous coronal slices of 0.5 mm thickness were acquired using a repetition time (TR) of 2 s and an echo time (TE) of 25.1 ms. Two Shinnar-Le Roux (SLR) pulses of 1 ms each were used for excitation and inversion, respectively. Twenty averages were acquired for each slice and the 128 3 64 pixel resolution images were zero-filled to 256 3 256 pixel resolution, resulting in an in-plane spatial resolution of 100 mm 3 100 mm 2 . Sixteen different images were acquired for each slice, 15 corresponding to various non-collinear diffusionweighting directions with b 5 1,000 s mm 22 and one with no diffusion weighting. DTI processing and analysis was performed blindly as described previously 45, 46 . CAPs. Compound action potential (CAP) recordings were performed in all four groups at P30 and P60 using methods previously described 4, 39 . Briefly, after mice were killed, coronal slices 400 mm in thickness were obtained using a VT1000S vibratome (Leica) in ice-cold slicing solution (85 mM NaCl, 2.5 mM KCl, 25 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 0.5 mM CaCl 2 , 7 mM MgCl 2 , 25 mM glucose, 75 mM sucrose). Slices were placed in recording solution (125 mM NaCl, 2.5 mM KCl, 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 2.5 mM CaCl 2 , 1.3 mM MgCl 2 , 11 mM glucose, pH 7.4) bubbled in 95% O 2 and 5% CO 2 , and maintained at 37 uC for 1 h then kept in the same solution at room temperature until recording. CAP recordings were performed on five slices corresponding to sections 13-18 (Bregma 1.32 to 20.94 mm) of the National Institutes of Mental Health's mouse brain atlas (http:// www.mbl,org/atlas170/atlas170_frame.html). Slices were placed in a recording chamber superfused with oxygenated recording solution at a flow rate of 2 ml min 21 and viewed using the 310 objective of an Olympus BX61WI microscope. CAP recordings were obtained using an FHC concentric bipolar stimulating electrode and an extracellular field electrode with a tip resistance of 1 MV. The stimulating and recording electrodes were placed ,2 mm apart (,1 mm on each side of the midline) in the corpus callosum of subcortical white matter, and a constant stimulus was delivered for each recording in current clamp. A single pulse protocol was used with a pulse frequency of 200 Hz and a period of 5 ms. Fifty sweeps were recorded, averaged and used in the analysis for CAP amplitude. Two distinguishable downward waves were evident for each CAP recording, with the first corresponding to rapidly propagating myelinated (M) axons and the second to slower propagating unmyelinated (UM) axons 4, 39, 47 . 1 H-NMR. Brains from all groups were collected at P11, P18 and P30. The brains were removed and placed on dry ice. The white matter was dissected, snap frozen in liquid nitrogen (total time ,60 s), and stored in a 280 uC freezer until extraction. Samples for 1 H-NMR spectroscopy were prepared as previously published 48 . Each frozen sample was homogenized in 1 ml of 7% perchloric acid and centrifuged for 10 min at 4 uC and 4,600g. Supernatants were transferred to separate tubes and pellets were re-extracted. Combined supernatants were neutralized with KOH, centrifuged and lyophilized. Lyophilized samples were dissolved in 0.8 ml of 99% D 2 O and pH was adjusted to 7.0. Fully relaxed 1 H-NMR spectra waere acquired on Varian 500 with the following parameters: 90u pulse angle, an acquisition time of 1.36 s, relaxation delay of 17 s, total number of 800 scans per sample. Low-power pre-saturation pulse at water frequency was used to achieve water suppression. Obtained spectra were analysed using MestReNova software (version 8.1; Mestrelab Research) and the amounts of metabolites were quantified from integrals of the peak areas corrected for number of protons and using 2,2,3,3-D(4)sodium-3-trimethylsilylpropionate as an internal control. Behavioural testing. Each behavioural experiment was performed in separate naive mice that had not undergone any previous behavioural testing. The complex running wheel task was performed as previously described [14] [15] [16] . At P45, naive mice that had not undergone any previous behavioural testing were individually housed in a modified cage equipped with a running wheel attached to an optical sensor to constantly detect the number of wheel revolutions per time interval (minute). Animals were kept on a regular 12 h light/dark cycle. Food and water were made available ad libitum. During the first 2 weeks, a training wheel with all 38 rungs was present, allowing for normalization of running behaviour. On the third week (day 15; age P60), the regular training wheel was replaced with a complex wheel of the same diameter with 22 rungs missing in an alternative pattern. Using Activity Wheel Monitoring Software (Lafayette Instruments), wheel revolutions were recorded each day and exported to a Microsoft Excel file in which daily total distance travelled and maximum daily velocity were calculated. All mice showed spontaneous running behaviour and no mice were excluded from this study. The inclined beam-walking task was performed as previously described 17, 18 . Two elevated 80 cm in length wooden beams were placed at a 30u angle. One beam was 2 cm in width and the other was 1 cm in width. A dark box with bedding was at the end of the incline and served as a target for the mouse to reach. A blinded experimenter observing and recording from above assessed mouse performance by documenting the number of foot slips (either hind legs or front legs) and the time to traverse the beam 18 . In pilot studies, we determined that hypoxia-exposed Rep mice less than 30 days of age-or on a beam that was inclined more than 30uwere unable to perform this task (data not shown). To confirm whether this sensorimotor task is dependent on subcortical white matter, bilateral LPC-or 0.9% saline-injected adult mice were tested on day 5 after surgery (described earlier). Bilateral demyelination was confirmed after testing by removal of brains and immunohistochemical analysis of corpus callosum. Only mice that had clear bilateral lesions on microscopic examination were included in the behavioural analysis (n 5 3 mice were excluded due to failure in demyelination). Statistics. All data in histograms are presented as averages 6 s.e.m. All cell counting and western blot data were statistically compared using one-way ANOVA to determine whether overall differences exist across study groups. Comparisons between specific groups were treated as unplanned comparisons, which were adjusted using a Bonferroni correction. A two-tailed type 1 error (P value , 0.05) was used to determine statistical significance. Each experiment evaluated outcomes in four groups. The Bonferroni correction was applied for the following comparisons: normoxia (Nx) a versus Nx b ; Nx a versus hypoxia (Hyp) a ; and Nx b versus Hyp b . The two hypoxia groups were compared post-hoc if the one-way ANOVA was significant using a two-tailed unpaired t-test (Hyp a versus Hyp b ) with two-tailed type 1 error set at P 5 0.05. For the electron microscopy data, a one-way ANOVA was used to compare the g ratio for each mouse in each of the four respective groups. If significance was found, then a two-tailed unpaired t-test with two-tailed type 1 error set at P 5 0.05 was used to make the following comparisons: Nx a versus Hyp a ; Hyp a versus Hyp b ; Nx a versus Nx b ; and Nx b versus Hyp b . Scatter plots of g ratios of individual fibres in relation to axon diameter are shown comparing the groups outlined earlier. The average FA anisotropy for each mouse in each group was compared using a one-way ANOVA as described earlier. The Bonferroni correction was applied for the following comparisons: Nx saline versus Hyp saline; Nx saline versus Hyp HB-EGF; and Hyp saline versus Hyp HB-EGF. For the complex running wheel data, we used a longitudinal linear regression analysis to compare slopes (trajectories) of change. We also performed post-hoc testing RESEARCH LETTER between the four groups for each individual day. For the beam-walking behavioural results, the number of foot slips, the time to traverse the beam and the size of the beam were analysed using a Poisson multiple regression analysis, which allowed us to overcome the lack of normality in count-type data and account for other variables to compare the rate of foot slips. The one-way ANOVA with post hoc comparisons was performed using GraphPad Prism 5.0 (for Mac). All histograms and scatter plots in this manuscript were created with GraphPad Prism.
Extended Data Figure 3 | The inclined beam-walking task requires normal subcortical white matter. a-c, This study was performed to test the hypothesis that the inclined beam-walking task is a good assessment of subcortical white matter function. To test this hypothesis, we tested a well-established model of subcortical white matter demyelination induced by bilateral lysolecithin injections in 8-week-old C57BL/6J male and female mice. Animals were tested at 5 days after surgical intervention-which is a time period when demyelination is at its maximum-to determine whether subcortical white matter integrity is important in this behavioural task. Control mice received bilateral injections of normal saline using the same coordinates as the lysolecithin group. a, b, Bilateral demyelination was confirmed after testing by removal of brains and immunohistochemical analysis of corpus callosum. Only mice that had clear bilateral lesions on microscopic examination were included in the behavioural analysis (n 5 3 mice were excluded). c, The lysolecithin-injected mice had a marginally significant or very significant increase in average number of foot slips on the 2-cm-and-1-cm-wide inclined beam, respectively (two-tailed Mann-Whitney test, n 5 6 per group). d, We wanted to determine whether the performance of Rep (CNP-eGFP) transgenic mice on the inclined beam-walking task was similar to that of C57BL/6 mice (wild type). No difference in performance was evident between the two different lines of male mice. We found that the Rep and wild-type mice performed similarly in either normoxic or hypoxic conditions (Poisson multiple regression analysis; Nx Rep, n 5 7; Nx wild type, n 5 11; Hyp Rep, n 5 8; Hyp wild type, n 5 11). All histograms are presented as means 6 s.e.m. *P 5 0.05; **P , 0.05; ***P , 0.01.
Extended Data Figure 5 | Intranasal HB-EGF does enter the brain and activates EGFRs in oligodendrocyte lineage cells. a-c, Saline or HB-EGF was administered intranasally once in P11 mice, which were then killed at 1, 5, 15 and 30 min after administration. a, Western blot analysis was performed on microdissected white matter probing for actin, HB-EGF and pEGFR (Tyr 1068 phosphorylation site). In the saline group, no HB-EGF was detected in the white matter and no change in pEGFR was detected. In the mice that received HB-EGF, the HB-EGF protein was detected at 5 min and increased up to 30 min. The pEGFR signal steadily increased at 5, 15 and 30 min after HB-EGF administration. b, c, The line graphs represent relative abundance of protein compared with actin (n 5 3 for each time point and condition). Line graphs are presented as means 6 s.e.m. d, A normoxia-treated P11 mouse was administered HB-EGF and killed 30 min later. Immunohistochemistry of pEGFR was performed. In the white matter, there were several Rep 1 pEGFR 1 DAPI 1 cells, indicating that oligodendrocyte lineage cells express activated EGFR (pEGFR). Shown is a 340 representative image of the white matter demonstrating Rep 1 pEGFR 1 DAPI 1 cells. e, In this set of experiments, Hyp Rep mice received either intranasal saline or HB-EGF from P11-P14 (Fig. 3b ). The subcortical white matter was microdissected at P15 and CNP-eGFP 1 cells were FACS purified. Western blot analysis was performed to probe for pEGFR. The western blot demonstrates that a more robust signal for pEGFR was present in the Hyp HB-EGF group, relative to actin (n 5 4 for each group of 2-3 pooled brains).

